Skip to main content
    E

    Eledon Pharmaceuticals Inc (ELDN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.98
    +0.01 (+0.51%)

    Market Cap: $178.63M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Eledon Pharmaceuticals Inc (ELDN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Eledon Pharmaceuticals (ELDN) has a market cap of $178.63M and an enterprise value of $171.75M. Its share count is up 48.69% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 3.85% below the market cap, as cash exceeds debt.

    Market Cap$178.63M
    Enterprise Value$171.75M
    Latest price (Nov 17, 2026)$1.98

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.96% in the quarter ended Sep 30, 2026 and grew 48.61% a year over 2 years.

    Shares Outstanding114.72M
    Shares Change (YoY)+48.69%
    Shares Change (QoQ)+0.96%
    Share Count Growth (2Y CAGR)+48.61%

    Price Statistics

    The stock is up 12.50% over 52 weeks and trades 21.43% below its 50-day average.

    Beta (1Y)1.84
    52-Week Change+12.50%
    1-Month Change-8.33%
    3-Month Change-44.23%
    6-Month Change-44.69%
    5-Year Change-44.60%
    10-Year Change-98.44%
    Total Return (1Y)+12.50%
    Total Return (3Y CAGR)+15.95%
    Total Return (5Y CAGR)-19.07%
    Return vs SPY (1Y)+17.01%
    Max Drawdown (1Y)-53.21%
    Max Drawdown (3Y)-73.77%
    Sharpe Ratio (1Y)0.37
    Correlation with SPY (1Y)0.37
    50-Day Average$2.52
    200-Day Average$3.12
    52-Week Range$1.35 to $4.49
    RSI (14 Days)36.2
    Average Volume (20 Days)965.55K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.30x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.30x
    Quick Ratio6.30x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -276.12% and return on assets is -79.74% over the last 12 months.

    Return on Equity (ROE)-276.12%
    Return on Assets (ROA)-79.74%
    Return on Capital Employed (ROCE)-89.53%
    ROA (5Y Average)-58.65%
    ROIC (5Y Average)-56.22%

    Scores

    ELDN has a Piotroski F-Score of 0 of 9, in the weak band of 0 to 2.

    Piotroski F-Score0 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$87.21M
    Pretax Income-$85.00M
    Net Income-$85.03M
    EBITDA-$85.00M
    EBIT-$85.00M
    Reported EPS (TTM)-$0.80

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 28.88% of the $106.64M in total assets.

    Cash and Equivalents$6.88M
    Total Debt$0
    Net Cash$6.88M
    Net Cash Per Share$0.06
    Working Capital$62.01M
    Shareholder Equity$30.80M
    Book Value Per Share$0.27
    Total Assets$106.64M
    Total Liabilities$36.83M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$78.36M
    FCF Per Share-$0.96

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    ELDN does not pay a dividend.

    Buyback Yield-23.59%
    Shareholder Yield-23.59%

    Stock Splits

    The last split was a 1-for-18 reverse split on Oct 5, 2020.

    Last Split DateOct 5, 2020
    Split TypeReverse split
    Split Ratio1:18

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ELDN

    What is ELDN's market cap?

    Eledon Pharmaceuticals has a market cap of $178.63M. Its enterprise value, which adds debt and subtracts cash, is $171.75M.

    How many shares of ELDN are outstanding?

    Eledon Pharmaceuticals has 114.72M shares outstanding. The count is up 48.69% from a year earlier.

    Does ELDN pay a dividend?

    No. Eledon Pharmaceuticals does not pay a dividend.

    How much debt does ELDN have?

    Eledon Pharmaceuticals has $0 of total debt and $6.88M of cash and equivalents, a net cash position of $6.88M.